Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
FTCCE9EgnjXcmFn7
Listen
